Mentor joins bidding war with offer to acquire Medicis

Mentor has offered $2.2 billion in stock to buy Medicis in a bid to emerge as a dominant player in the cosmetic drug business. Santa Barbara, CA-based Mentor makes urological products. But Medicis immediately rejected the offer, instead reaffirming its own bid to buy the breast implant maker Inamed. Allergan, which makes Botox, has also made a bid to buy Inamed.

- read this report from MarketWatch for more

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.